STAR — Strides Pharma Science Share News
0.000.00%
Last trade - 00:00- IN₹93.54bn
- IN₹107.43bn
- IN₹48.59bn
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees
Brief: Strides Pharma Science Enters Agreement To Buy, In-License Generic Brands From Sandoz In Africa
Brief: Strides Pharma Science Says Unit Gets USFDA EIR Report For Formulations Facility At Chestnut Ridge
Brief: Strides Pharma Science Ltd Dec-Quarter Consol Net Profit 2.02 Billion Rupees
India's Strides Pharma Science drops after FDA observations for US facility
Brief: Strides Pharma Science Says Completion Of US-FDA Inspection At Co's USA Facility
India's Strides Pharma Science hits record high on quarterly profit surge
Brief: Strides Pharma Science Sept-Quarter Consol Net Profit 1.28 Billion Rupees
Brief: Strides Pharma Science Partners With Kenox To Expand Nasal Spray Portfolio
Brief: Strides Pharma Science Says Unit To Divest 100% Stake In Strides CIS
India's Strides Pharma rises on quarterly profit surge, boosted by US sales
Brief: Strides Pharma Science, Arco Lab Approve Demerger Of Identified Business Of Arco Lab
Brief: Strides Pharma Science Unit Proposes To Acquire 100% Stake In Amexel
India's Strides Pharma Science jumps after Q3 profit rise
Indian pharma stocks gain after US resumes funding HIV treatments
Brief: Strides Pharma Science Dec-Quarter Consol Net Profit 879.5 Million Rupees